Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

Value stocks are low-priced compared to their financial performance. Investing in value stocks is beneficial when market prices are low. Focusing on value stocks can maximize long-term investment ...

These smaller or newer companies may offer unique value propositions and growth prospects ... company dev Eight participants achieved HBsAg loss at any time.Two participants met criteria for ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

Data from the B-Clear study also showed that patients with low baseline HBsAg levels were most likely ... with milestone payments taking the value of the deal up to $262 million.

stevecoleimages / Getty Images Book value per common share, also known as book value per equity of share (BVPS), evaluates the stock price of an individual company. Net asset value (NAV ...

In B-Clear, patients with low baseline HBsAg levels responded best to treatment ... paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

The 2024 WHO HBV guidelines conditionally recommend that when pregnant individuals are unable to access viral load testing, all those who are HBsAg positive should be offered tenofovir to prevent ...

Two of three participants showed a substantial reduction in HBsAg after the first dose, supporting early antiviral activity. Next: Get access to a new market-moving chart every day featuring a ...

Beyond azer-cel, Precision’s proprietary ARCUS genome editing platform holds great value. Their strategic ... known as hepatitis B surface antigen ((HBsAg)). Given that these results are ...

The following is a summary of “Advance directives in the intensive care unit: An eight-year vanguard cohort study,” published in the February 2025 issue of Journal of Critical Care by Baumann et al.